Amidas

7-Phenylacetamide-3-chloromethyl-3-cephem-4-carboxylic acid diphenylmethyl ester is an organic solution that is used in the detoxification of chemical substances. It has a hydroxyl group and is soluble in nonpolar solvents. 7PAMC has been shown to be effective against bone lesions caused by acylation reactions. This drug also binds to the enzyme called cytochrome P450, which is involved in the metabolism of many drugs. It also inhibits bacterial growth by binding to DNA gyrase and topoisomerase IV, enzymes that maintain bacterial DNA integrity. The particle size of this drug is small, with a diameter of less than 10 microns. 7PAMC has a viscosity of 1 cps at 25°C and a melting point of 129°C.

<p>Please enquire for more information about N-(2-Cyano-4-oxo-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

Fluoxetine is a potent inhibitor of the enzyme cytochrome P450 (CYP) 2C19. The inhibition of CYP2C19 by fluoxetine may lead to an increase in the plasma concentration of other drugs that are metabolized by this enzyme, such as glipizide and hydroxycyclohexyl. Fluoxetine inhibits human uric acid secretion and increases plasma concentrations of uric acid. This drug also inhibits human erythrocyte dihydropyrimidine dehydrogenase, leading to increased blood levels of pyrimidines, especially cytotoxic ones like 6-fluoro-3-indoxyl-beta-D-galactopyranoside. Fluoxetine has been shown to have a protective effect against acetaminophen toxicity in rats because it enhances the conversion of acetaminophen to its less toxic metabolite N-acetylcysteine.

Please enquire for more information about 2-Cyano-N-cyclohexyl-N-methylacetamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

<p>N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide is an anticancer drug that belongs to the class of phenethyl derivatives. It is a radiosensitizer that inhibits DNA and RNA synthesis, leading to cancer cell death. The drug has been shown to have a chiral center and two enantiomers, with the (S)-enantiomer being more active than the (R)-enantiomer. N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide has been shown to be effective in animal models for brain tumors and breast cancer cells. It has also been shown to be effective against leukemia cells, which are resistant to other treatments. N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4</p>

<p>N-Bromoacetamide is a reactive chemical that can react with the sodium channel to produce a postulated effect. It has been shown to inhibit the kinetics of the sodium channel in whole-cell voltage clamp experiments. This inhibition is reversible and does not depend on the pH of the solution. Bromoacetamide has been shown to have an irreversible inhibition on potassium channels, which may be due to its ability to form covalent bonds with sulfhydryl groups. Bromoacetamide also inhibits voltage-gated calcium channels, but at a slower rate than it does for sodium channels. N-Bromoacetamide has been shown to be effective in pharmacological treatments for epilepsy, myasthenia gravis, and multiple sclerosis.</p>

<p>N-Desmethyl loperamide is a prodrug of loperamide, which is a peripherally acting μ-opioid receptor agonist. It has been shown to be effective in reducing the uptake of radiation in wild-type mice. This drug also inhibits p-glycoprotein (p-gp), and has been shown to reduce the uptake of pyridinium ions and amide substrates. N-Desmethyl loperamide has been shown to have anticancer properties, including resistance to radiation, inhibition of tumor growth and metastasis, and induction of apoptosis, which may be due to its ability to inhibit cellular proliferation and induce cell death. The mechanism by which this drug functions is not yet clear but it may involve inhibition of the expression or function of p-gp or other efflux pumps in cells that are sensitive to these drugs.</p>

Please enquire for more information about 3-(2-Ethyl-1H-benzimidazol-1-yl)propanamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

<p>Lacosamide is an antiepileptic drug that has been shown to be bioequivalent to the reference product, Gabapentin. Lacosamide binds to voltage-gated sodium channels and is thought to have a similar clinical profile as Gabapentin. It is used in the treatment of partial seizures (with or without secondary generalization) and adjunctive therapy for generalized seizures in adults and children aged 2 years or older. Lacosamide can interact with other drugs, such as gabapentin, by increasing their serum concentrations. This interaction may lead to adverse effects such as dizziness and confusion. Lacosamide plasma concentrations are measured using LC-MS/MS methods after a two-way crossover study in healthy human volunteers. This study also showed that lacosamide is excreted unchanged in urine samples at a rate of about 50% over 24 hours, indicating that it does not undergo extensive metabolism in humans.</p>

<p>Please enquire for more information about 4-(Aminomethyl)-N-Methylbenzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about N,N-Dimethyl 4-boronobenzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

N'-Hydroxycyclopropanecarboximidamide (N-HCPC) is an alkoxycarbonyl-containing heterocycle that is structurally related to the benzodiazepine class of drugs. It has been shown to have depressant activity in animal models and may be useful as a treatment for epilepsy, but it also has psychoactive properties. N-HCPC can cause epileptic seizures in humans, although this effect appears to be dose dependent. It may also have potential use as a treatment for Alzheimer's disease and depression due to its ability to bind to the benzodiazepine receptor. The drug binds with high affinity to muscle tissue, which may explain its effects on muscle control and movement.

<p>Please enquire for more information about 2-Chloro-N-(2,3-dihydro-1H-inden-2-yl)acetamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about (NZ)-4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene]benzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>4-(3-Amino-2-hydroxypropoxy)phenylacetamide is a sweetener that is used as an artificial sweetener. It can be found in many foods and drinks and is often used to replace sucralose due to its lower cost. 4-(3-Amino-2-hydroxypropoxy)phenylacetamide is a white powder with a melting point of 133°C. This product has been shown to be safe for human consumption, although it may cause headaches, drowsiness, or dizziness in some people.</p>

<p>Please enquire for more information about N,N-bis(2-Chloroethyl) benzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about 2-(2,5-Dimethoxyphenyl)ethylformamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

6-Chloro-3,4-dihydro-3-(a-methylbenzyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide is an active metabolite of the drug benzbromarone. It is primarily administered as a diuretic to treat high blood pressure and congestive heart failure. The pharmacodynamics of this drug are related to its ability to inhibit the activity of sodium channels in vascular smooth muscle cells and thereby reduce the force of contraction and relax the vessel wall. 6CBDMTD has shown an increase in glomerular filtration rate in patients with congestive heart failure. This drug also decreases the plasma concentration of fatty acids by inhibiting the formation of lipoprotein particles. 6CBDMTD has been shown to be effective at lowering diastolic and systolic blood pressure levels in patients with hypertension.

<p>Please enquire for more information about 16-Phenoxy tetranor pgf2alfa cyclopropyl methylamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about 4-(2-Chloro-4-nitrophenyl)piperazine-1-carboxamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>